Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-02

Clinical Trial Update: Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and efficacy of Squaric Acid Dibutyl Ester for herpes labialis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Squaric Acid Dibutyl Ester (Squaric acid dibutyl ester)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Herpes Labialis | Phase 1 | Status: COMPLETED | Results posted: 2017-10-02